View More Recent Stories

Sep 9, 2013 08:29AM Rigel Pharma (RIGL) Plans to Shift Fostamatinib Focus From RA to ITP an 'Incremental Positive' - Jefferies
Aug 29, 2013 06:58AM Jefferies Starts Stemline Therapeutics (STML) at Buy, Sees 77% Upside
Aug 14, 2013 07:24AM CaPre to Have Minimal Impact on Amarin (AMRN) Vascepa Sales - Jefferies
View More Recent Stories